eCM (Eur Cell Mater / e Cells & Materials) eCM Open Access Scientific Journal
 ISSN:1473-2262         NLM:100973416 (link)         DOI:10.22203/eCM

eCM Journal (European Cells & Materials, ISSN: 1473-2262)

eCM open access Scientific Journal

Starting from August 2023, open access scientific journal European Cells & Materials has changed publisher from AO Research Institute Davos (ARI) to Forum Multimedia Publishing, LLC., Part of IMR Press. Prof. R. Geoff Richards continues to serve as the Editor-in-Chief of eCM Journal. Forum Multimedia Publishing has adiusted the charging policy, eCM is now free of submission fees.

eCM Journal (European Cells & Materials) provides an interdisciplinary forum for publication in the musculoskeletal field (Orthopaedics, Trauma, Maxillofacial (including dental) and Spine) of preclinical research, including the field of tissue engineering & regenerative medicine.

eCM Journal Impact Factor 2022: 3.1. JCR 5-year Impact Factor: 4.1 SJR H index: 96.

Just released: Scopus CiteScore 2022: 6.1

Temporo-mandibular joint Special Issue: The temporomandibular joints (TMJs) connect the jaw to the skull and are the most used joints of the human body. TMJ disorders (TMD) are severely debilitating and a significant public health issue. Therapies for TMD have mixed success so there is a great need for new research into the TMJ to prompt therapies that are more effective. The eCM journal is facilitating this by producing a special issue focused on the TMJ, which serves as a platform for the publication of manuscripts describing novel basic science on TMJ development, growth, homeostasis, pathologies and therapies.
Submission deadline: 31st of March 2023

Read more about the special issues

Gene therapy for musculoskeletal applications Special Issue: The COVID-19 pandemic has shown how revolutionary treatments based on gene therapeutics have helped overcome a once-in-a-century pandemic and have given new momentum to gene therapy research for a myriad of applications. In musculoskeletal applications, this might provide an opportunity to overcome some of the well-established problems with therapeutics, such as recombinant bone morphogenetic proteins. This special issue will include a series of articles focused on viral and non-viral gene therapy approaches for delivery of DNA and RNA therapeutics to repair musculoskeletal tissues including bone, cartilage, ligament, tendon, meniscus, intervertebral disk and peripheral nerve.
Submission deadline: 31st of July 2023

Read more about the special issues

What are your colleagues citing? (Accurate as of 22nd May 2024)

Recent Papers: